Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment

Summary

Primary Objective: \- To assess potential impact of moderate and severe renal impairment on the pharmacokinetics of cabazitaxel Secondary Objective: \- To assess the safety of cabazitaxel in patients with various degrees of renal impairment

Timeline

Start

2012-04

Primary completion

2013-11

Completion

2013-11

Drugs

Indications